Maureen Lynes
About Maureen Lynes
Maureen Lynes is the Director of Biology at Accent Therapeutics, Inc., where she provides strategic direction for small molecule oncology programs. She has extensive experience in oncology, neurobiology, and immuno-oncology, and has held various roles in research and leadership across multiple organizations.
Current Role at Accent Therapeutics
Maureen Lynes serves as the Director of Biology at Accent Therapeutics, Inc., a position she has held since 2022. In this role, she provides strategic direction for small molecule oncology programs at various stages of development. Her responsibilities include managing cross-functional teams and ensuring the successful progression of oncology projects. Lynes has a focus on integrating scientific research with practical applications in the field of oncology.
Previous Experience at Accent Therapeutics
Prior to her current role, Maureen Lynes worked at Accent Therapeutics, Inc. as a Principal Scientist from 2019 to 2021. During this time, she contributed to various projects in the oncology sector. Before that, she held the position of Associate Director at Accent Therapeutics for one year, from 2021 to 2022. Her experience at Accent Therapeutics has equipped her with a deep understanding of the company's goals and operational strategies.
Experience at FORMA Therapeutics
Maureen Lynes has significant experience from her tenure at FORMA Therapeutics, Inc., where she worked as a Senior Scientist in Discovery Biology from 2017 to 2019. She was involved in various oncology research initiatives during her two years at the company. Additionally, she served as a Scientist in Biology at FORMA Therapeutics from 2014 to 2017, contributing to the development of innovative therapeutic approaches in oncology.
Educational Background
Maureen Lynes earned her Ph.D. in Cellular and Molecular Physiology from Tufts University School of Medicine, where she studied from 2005 to 2010. Prior to her doctoral studies, she completed her Bachelor of Arts in Biology at Colby College from 2001 to 2005. Her educational background provides her with a strong foundation in biological sciences, which supports her current research and leadership roles.
Research Contributions and Presentations
Maureen Lynes has actively contributed to the scientific community, including presenting a poster on the inhibition of KIF18A at the AACR 2024 Annual Meeting. Her research focuses on oncology, neurobiology, and immuno-oncology, reflecting her expertise in managing cross-functional teams and leading high-performing research initiatives.